EMT cards

1. Aspirin (Bayer)
  • Generic / Trade Name: Aspirin / Bayer, Bufferin, Ecotrin

  • Mechanism of Action: Anti-platelet aggregate; inhibits cyclooxygenase and prevents platelets from clumping together, reducing blood clot formation.

  • Indications: Chest pain or discomfort suggestive of acute coronary syndrome (ACS) / myocardial infarction (MI).

  • Contraindications: Hypersensitivity/allergy to aspirin, active gastrointestinal (GI) bleeding, bleeding disorders, pediatric patients with viral illness (risk of Reye syndrome).

  • Route of Administration: Oral (chewable).

  • Dosage:

    • Adult: 162 mg162\,\text{mg} to 324 mg324\,\text{mg} (22 to 44 chewable 81 mg81\,\text{mg} tablets).

    • Pediatric: Not indicated in emergency prehospital settings.

  • Side Effects: Nausea, vomiting, heartburn, epigastric pain, GI bleeding, bronchospasm in aspirin-sensitive asthmatics.

  • Interactions: Increases risk of bleeding when taken with other anticoagulants or NSAIDs.

  • Administration Concerns: Must be chewed prior to swallowing for rapid absorption. Ensure patient can maintain an open airway and swallow.

  • Onset of Action: 55 to 30 minutes30\,\text{minutes}.

  • Peak Effect: 11 to 2 hours2\,\text{hours}.

2. Albuterol (Proventil, Ventolin)
  • Generic / Trade Name: Albuterol / Proventil, Ventolin, Volmax

  • Mechanism of Action: Selective beta-2 adrenergic agonist; relaxes bronchial smooth muscle, causing bronchodilation.

  • Indications: Bronchospasm associated with asthma, COPD, bronchitis, or anaphylaxis.

  • Contraindications: Hypersensitivity, severe tachycardia secondary to underlying cardiac conditions.

  • Route of Administration: Inhalation via Metered-Dose Inhaler (MDI) or Small Volume Nebulizer (SVN).

  • Dosage:

    • Adult: MDI: 11 to 22 puffs (90 μg90\,\mu\text{g} per puff); Nebulizer: 2.5 mg2.5\,\text{mg} in 3 mL3\,\text{mL} normal saline administered over 1010 to 15 minutes15\,\text{minutes}.

    • Pediatric: Nebulizer: 1.25 mg1.25\,\text{mg} to 2.5 mg2.5\,\text{mg} in 3 mL3\,\text{mL} normal saline.

  • Side Effects: Tachycardia, tremors, anxiety, hypertension, dizziness, dry mouth, palpitations.

  • Interactions: Beta-blockers may antagonize bronchodilating effects; MAOIs may increase cardiovascular risk.

  • Administration Concerns: Monitor vital signs and lung sounds before and after administration. Set nebulizer flow rate at 66 to 8 L/min8\,\text{L/min}.

  • Onset of Action: 55 to 15 minutes15\,\text{minutes}.

  • Peak Effect: 30 minutes30\,\text{minutes} to 2 hours2\,\text{hours}.

3. Activated Charcoal (Actidose-Aqua)
  • Generic / Trade Name: Activated Charcoal / Actidose-Aqua, Liqui-Char

  • Mechanism of Action: Adsorbs ingested toxic substances and chemicals in the GI tract, preventing systemic absorption.

  • Indications: Acute oral poisonings and medication overdoses (best within 1 hour1\,\text{hour} of ingestion).

  • Contraindications: Unconscious patient or unprotected airway, ingestion of corrosives (acids/alkalis), heavy metals, or petroleum distillates.

  • Route of Administration: Oral (PO).

  • Dosage:

    • Adult: 1 g/kg1\,\text{g/kg} of body weight (typically 2525 to 50 g50\,\text{g}).

    • Pediatric: 1 g/kg1\,\text{g/kg} of body weight (typically 12.512.5 to 25 g25\,\text{g}).

  • Side Effects: Black stools, nausea, vomiting, constipation, abdominal cramps.

  • Interactions: Inactivates other orally administered medications or emetics.

  • Administration Concerns: Shake slurry container vigorously before administration; risk of severe aspiration pneumonitis if aspirated.

  • Onset of Action: Immediate upon contact with GI contents.

  • Peak Effect: Local action in GI tract; no systemic absorption.

4. Oxygen
  • Generic / Trade Name: Oxygen / O2O_2

  • Mechanism of Action: Increases arterial oxygen tension and cellular oxygenation.

  • Indications: Hypoxia, respiratory distress, trauma, cardiac arrest, shock, suspected carbon monoxide poisoning.

  • Contraindications: None in emergency settings (use caution in COPD patients with hypercapnic drive).

  • Route of Administration: Inhalation via Nasal Cannula, Non-Rebreather Mask (NRB), or Bag-Valve-Mask (BVM).

  • Dosage:

    • Adult & Pediatric:

    • Nasal Cannula: 11 to 6 L/min6\,\text{L/min} (24%24\% to 44%44\% FiO2FiO_2).

    • Non-Rebreather Mask: 1010 to 15 L/min15\,\text{L/min} (80%80\% to 90%90\% FiO2FiO_2).

    • BVM: 15 L/min15\,\text{L/min} (100%100\% FiO2FiO_2).

  • Side Effects: Mucosal dryness, airway irritation, hypoventilation in hypercapnic COPD patients.

  • Interactions: Strongly supports combustion (fire hazard).

  • Administration Concerns: Ensure oxygen cylinder is secured; pre-fill reservoir bag on NRB before applying to patient.

  • Onset of Action: Immediate.

  • Peak Effect: Immediate.

5. Naloxone (Narcan)
  • Generic / Trade Name: Naloxone / Narcan

  • Mechanism of Action: Competitive opioid receptor antagonist; displaces opioids from central nervous system receptor sites.

  • Indications: Known or suspected opioid overdose with respiratory depression and altered mental status.

  • Contraindications: Hypersensitivity to naloxone.

  • Route of Administration: Intranasal (IN), Auto-injector, Intramuscular (IM).

  • Dosage:

    • Adult: 2 mg2\,\text{mg} to 4 mg4\,\text{mg} IN (1 mg1\,\text{mg} per nostril using a mucosal atomizer device or single pre-packaged spray).

    • Pediatric: 0.1 mg/kg0.1\,\text{mg/kg} IN/IM (maximum single dose 2 mg2\,\text{mg}).

  • Side Effects: Acute opioid withdrawal (nausea, vomiting, sweating, tachycardia, agitation, combativeness).

  • Interactions: Reverses therapeutic and toxic effects of opioid analgesics.

  • Administration Concerns: Half-life of naloxone is often shorter than that of the opioid ingested; prepare for patient relapse into respiratory depression.

  • Onset of Action: 11 to 2 minutes2\,\text{minutes} (IN/IM).

  • Peak Effect: 55 to 15 minutes15\,\text{minutes}.

6. Oral Glucose (Insta-Glucose)
  • Generic / Trade Name: Oral Glucose / Insta-Glucose, Glutose

  • Mechanism of Action: Direct absorption of simple glucose into blood vessels to elevate blood glucose levels.

  • Indications: Hypoglycemia in conscious patients with altered mental status and confirmed blood glucose level <60 mg/dL< 60\,\text{mg/dL}.

  • Contraindications: Unconscious patient, inability to swallow or control airway, severe nausea or vomiting.

  • Route of Administration: Oral (buccal administration between cheek and gum).

  • Dosage:

    • Adult: 1515 to 45 g45\,\text{g} (11 tube typically contains 15 g15\,\text{g}).

    • Pediatric: 15 g15\,\text{g} (11 tube).

  • Side Effects: Nausea, potential airway compromise if aspirated.

  • Interactions: None significant in prehospital emergency settings.

  • Administration Concerns: Verify airway protection and swallowing ability before giving; administer slowly via buccal pouch using a tongue depressor or direct tube insertion.

  • Onset of Action: 1010 to 20 minutes20\,\text{minutes}.

  • Peak Effect: Varies with rate of absorption.

7. Nitroglycerin (Nitrostat)
  • Generic / Trade Name: Nitroglycerin / Nitrostat, Nitrolingual

  • Mechanism of Action: Vascular smooth muscle relaxant and vasodilator; decreases preload, systemic vascular resistance, and myocardial oxygen consumption.

  • Indications: Chest pain or discomfort associated with acute coronary syndrome or angina pectoris.

  • Contraindications: Systolic blood pressure <100 mmHg< 100\,\text{mmHg}, use of PDE-5 inhibitor medications for erectile dysfunction within 2424 to 48 hours48\,\text{hours} (e.g., sildenafil, tadalafil), head injury/intracranial bleeding, hypersensitivity.

  • Route of Administration: Sublingual (SL) tablet or spray.

  • Dosage:

    • Adult: 0.4 mg0.4\,\text{mg} SL every 5 minutes5\,\text{minutes} up to maximum 33 doses (if systolic BP remains >100 mmHg> 100\,\text{mmHg}).

    • Pediatric: Not indicated in prehospital care.

  • Side Effects: Headache, hypotension, dizziness, syncope, facial flushing, reflex tachycardia.

  • Interactions: Severe, life-threatening hypotension when administered with PDE-5 inhibitors.

  • Administration Concerns: Re-check blood pressure before each dose. Advise patient that burning or tingling under the tongue is normal.

  • Onset of Action: 11 to 3 minutes3\,\text{minutes}.

  • Peak Effect: 55 to 10 minutes10\,\text{minutes}.

8. Epinephrine 1:1000
  • Generic / Trade Name: Epinephrine (1:10001:1000 concentration) / Adrenalin

  • Mechanism of Action: Non-selective alpha and beta adrenergic agonist causing vasoconstriction (alpha-1), bronchodilation (beta-2), and increased cardiac output (beta-1).

  • Indications: Severe anaphylactic reactions with systemic involvement (respiratory compromise or shock).

  • Contraindications: None in a life-threatening anaphylactic emergency.

  • Route of Administration: Intramuscular (IM) injection (anterolateral thigh).

  • Dosage:

    • Adult: 0.3 mg0.3\,\text{mg} IM (0.3 mL0.3\,\text{mL} of 1:10001:1000 solution).

    • Pediatric: 0.15 mg0.15\,\text{mg} IM (0.15 mL0.15\,\text{mL} of 1:10001:1000 solution).

  • Side Effects: Tachycardia, palpitations, chest pain, anxiety, tremors, hypertension, dizziness.

  • Interactions: Potentiated by tricyclic antidepressants and MAO inhibitors.

  • Administration Concerns: Confirm correct concentration (1:10001:1000 vs 1:10,0001:10,000) and route (IM only for 1:10001:1000). Re-evaluate vital signs after injection.

  • Onset of Action: 33 to 5 minutes5\,\text{minutes}.

  • Peak Effect: 55 to 10 minutes10\,\text{minutes}.

9. Epi-pen (Adult Auto-Injector)
  • Generic / Trade Name: Epinephrine Auto-Injector / Epi-Pen

  • Mechanism of Action: Alpha and beta adrenergic agonist causing rapid peripheral vasoconstriction, bronchodilation, and reduction of capillary permeability.

  • Indications: Severe allergic reactions and anaphylaxis in adult patients.

  • Contraindications: None in life-threatening anaphylaxis.

  • Route of Administration: Intramuscular (IM) auto-injection into anterolateral thigh.

  • Dosage:

    • Adult: 0.3 mg0.3\,\text{mg} IM auto-injector.

    • Pediatric: N/A (will not have a pediatric dose; use Epi-Pen Jr).

  • Side Effects: Tachycardia, anxiety, palpitations, tremors, headache, hypertension, nausea.

  • Interactions: Synergistic cardiovascular effects when taken with other sympathomimetics.

  • Administration Concerns: Hold auto-injector firmly against mid-outer thigh for 33 to 10 seconds10\,\text{seconds}; massage site after injection to promote drug uptake.

  • Onset of Action: Rapid (within minutes).

  • Peak Effect: 55 to 10 minutes10\,\text{minutes}.

10. Epi-pen Jr (Pediatric Auto-Injector)
  • Generic / Trade Name: Epinephrine Auto-Injector Pediatric / Epi-Pen Jr

  • Mechanism of Action: Alpha and beta adrenergic agonist causing bronchodilation, peripheral vasoconstriction, and relief of upper airway edema.

  • Indications: Severe allergic reactions and anaphylaxis in pediatric patients weighing 1515 to 30 kg30\,\text{kg} (3333 to 66 lbs66\,\text{lbs}).

  • Contraindications: None in life-threatening anaphylactic emergencies.

  • Route of Administration: Intramuscular (IM) auto-injection into anterolateral thigh.

  • Dosage:

    • Adult: N/A (will not have an adult dose; use Epi-Pen).

    • Pediatric: 0.15 mg0.15\,\text{mg} IM auto-injector.

  • Side Effects: Tachycardia, restlessness, tremors, anxiety, palpitations, dizziness, pallor.

  • Interactions: Enhanced effect when combined with other sympathomimetic agents.

  • Administration Concerns: Confirm patient weight criteria (1515 to 30 kg30\,\text{kg}). Hold device firmly against outer thigh for 33 to 10 seconds10\,\text{seconds}.

  • Onset of Action: Rapid (within minutes).

  • Peak Effect: 55 to 10 minutes10\,\text{minutes}.